Response to Trametinib of a Pulmonary Langerhans Cell Histiocytosis Harboring a MAP2K1 Deletion

被引：27

作者：

Lorillon, Gwenael ^{[1
]}

Jouenne, Fanelie ^{[1
,2
]}

Baroudjian, Barouyr ^{[1
]}

de Margerie-Mellon, Constance ^{[1
,2
]}

Vercellino, Laetitia ^{[1
]}

Meignin, Veronique ^{[1
,3
]}

Lebbe, Celeste ^{[1
,2
,4
]}

Vassallo, Robert ^{[5
]}

Mourah, Samia ^{[1
,2
,4
]}

Tazi, Abdellatif ^{[1
,2
,6
]}

机构：

[1] AP HP, Paris, France

[2] Univ Paris Diderot, Paris, France

[3] INSERM, UMR S1165, Paris, France

[4] INSERM, U976, Paris, France

[5] Mayo Clin, Rochester, MN USA

[6] CRESS, U1153, Paris, France

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 198卷 / 05期

关键词：

ERDHEIM-CHESTER DISEASE; MUTATIONS; VEMURAFENIB; ACTIVATION;

D O I：

10.1164/rccm.201802-0275LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：675 / 678

页数：4

共 11 条

[1] Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study) [J].

Aubart, Fleur Cohen ;

Emile, Jean-Francois ;

Carrat, Fabrice ;

Charlotte, Frederic ;

Benameur, Neila ;

Donadieu, Jean ;

Maksud, Philippe ;

Idbaih, Ahmed ;

Barete, Stephane ;

Hoang-Xuan, Khe ;

Amoura, Zahir ;

Haroche, Julien .

BLOOD, 2017, 130 (11) :1377-1380

[2] Recurrent BRAF mutations in Langerhans cell histiocytosis [J].

Badalian-Very, Gayane ;

Vergilio, Jo-Anne ;

Degar, Barbara A. ;

MacConaill, Laura E. ;

Brandner, Barbara ;

Calicchio, Monica L. ;

Kuo, Frank C. ;

Ligon, Azra H. ;

Stevenson, Kristen E. ;

Kehoe, Sarah M. ;

Garraway, Levi A. ;

Hahn, William C. ;

Meyerson, Matthew ;

Fleming, Mark D. ;

Rollins, Barrett J. .

BLOOD, 2010, 116 (11) :1919-1923

[3] Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis [J].

Chakraborty, Rikhia ;

Burke, Thomas M. ;

Hampton, Oliver A. ;

Zinn, Daniel J. ;

Lim, Karen Phaik Har ;

Abhyankar, Harshal ;

Scull, Brooks ;

Kumar, Vijetha ;

Kakkar, Nipun ;

Wheeler, David A. ;

Roy, Angshumoy ;

Poulikakos, Poulikos I. ;

Merad, Miriam ;

McClain, Kenneth L. ;

Parsons, D. Williams ;

Allen, Carl E. .

BLOOD, 2016, 128 (21) :2533-2537

[4] Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis [J].

Chakraborty, Rikhia ;

Hampton, Oliver A. ;

Shen, Xiaoyun ;

Simko, Stephen J. ;

Shih, Albert ;

Abhyankar, Harshal ;

Lim, Karen Phaik Har ;

Covington, Kyle R. ;

Trevino, Lisa ;

Dewal, Ninad ;

Muzny, Donna M. ;

Doddapaneni, Harshavardhan ;

Hu, Jianhong ;

Wang, Linghua ;

Lupo, Philip J. ;

Hicks, M. John ;

Bonilla, Diana L. ;

Dwyer, Karen C. ;

Berres, Marie-Luise ;

Poulikakos, Poulikos I. ;

Merad, Miriam ;

McClain, Kenneth L. ;

Wheeler, David A. ;

Allen, Carl E. ;

Parsons, D. Williams .

BLOOD, 2014, 124 (19) :3007-3015

[5] Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study [J].

Diamond, Eli L. ;

Subbiah, Vivek ;

Lockhart, A. Craig ;

Blay, Jean-Yves ;

Puzanov, Igor ;

Chau, Ian ;

Raje, Noopur S. ;

Wolf, Jurgen ;

Erinjeri, Joseph P. ;

Torrisi, Jean ;

Lacouture, Mario ;

Elez, Elena ;

Martinez-Valle, Ferran ;

Durham, Benjamin ;

Arcila, Maria E. ;

Ulaner, Gary ;

Abdel-Wahab, Omar ;

Pitcher, Bethany ;

Makrutzki, Martina ;

Riehl, Todd ;

Baselga, Jose ;

Hyman, David M. .

JAMA ONCOLOGY, 2018, 4 (03) :384-388

[6] Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease [J].

Haroche, Julien ;

Cohen-Aubart, Fleur ;

Emile, Jean-Francois ;

Maksud, Philippe ;

Drier, Aurelie ;

Toledano, Dan ;

Barete, Stephane ;

Charlotte, Frederic ;

Cluzel, Philippe ;

Donadieu, Jean ;

Benameur, Neila ;

Grenier, Philippe A. ;

Besnard, Sophie ;

Ory, Jean-Paul ;

Lifermann, Francois ;

Idbaih, Ahmed ;

Granel, Brigitte ;

Graffin, Bruno ;

Hervier, Baptiste ;

Arnaud, Laurent ;

Amoura, Zahir .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) :411-U52

[7] Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease [J].

Kamionek, Michal ;

Moghaddam, Parnian Ahmadi ;

Sakhdari, Ali ;

Kovach, Alexandra E. ;

Welch, Matthew ;

Meng, Xiuling ;

Dresser, Karen ;

Tomaszewicz, Keith ;

Cosar, Ediz F. ;

Mark, Eugene J. ;

Fraire, Armando E. ;

Hutchinson, Lloyd .

HISTOPATHOLOGY, 2016, 69 (03) :499-509

[8] Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes [J].

Lee, Lynn H. ;

Gasilina, Anjelika ;

Roychoudhury, Jayeeta ;

McCormack, Francis X. ;

Pressey, Joseph ;

Grimley, Michael S. ;

Lorsbach, Robert ;

Ali, Siraj ;

Bailey, Mark ;

Stephens, Philip ;

Ross, Jeffrey S. ;

Miller, Vincent A. ;

Nassar, Nicolas N. ;

Kumar, Ashish R. .

JCI INSIGHT, 2017, 2 (03)

[9] Cladribine Is Effective against Cystic Pulmonary Langerhans Cell Histiocytosis [J].

Lorillon, Gwenael ;

Bergeron, Anne ;

Detourmignies, Laurence ;

Jouneau, Stephane ;

Wallaert, Benoit ;

Frija, Jacques ;

Tazi, Abdellatif .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (09) :930-932

[10] Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis [J].

Mourah, Samia ;

How-Kit, Alexandre ;

Meignin, Veronique ;

Gossot, Dominique ;

Lorillon, Gwenael ;

Bugnet, Emmanuelle ;

Mauger, Florence ;

Lebbe, Celeste ;

Chevret, Sylvie ;

Tost, Joerg ;

Tazi, Abdellatif .

EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (06) :1785-1796

← 1 2 →